FK506 and erectile function preservation in the cavernous nerve injury model: Optimal dosing and timing

Journal of Sexual Medicine

Volumn 5, Issue 6, 2008, Pages 1334-1344

  Mulhall, John P ^a,b   Müller, Alexander ^a,b   Donohue, John F ^b   Golijanin, Dragan ^b   Tal, Raanan ^b   Akin Olugbade, Yemi ^a   Kobylarz, Keith ^a   Cohen Gould, Leona ^a   Bennett, Nelson E ^c   Scardino, Peter ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Core Facility for Electron Microscopy ^*

Author keywords

Animal Model; Cavernous Nerve Injury; Erectile Function Preservation; FK506; Immunophilin Ligand

Indexed keywords

NERVE GROWTH FACTOR; NEUROMODULIN; NEURONAL NITRIC OXIDE SYNTHASE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAVERNOUS NERVE INJURY; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG DOSE COMPARISON; DRUG MEGADOSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; NERVE CRUSH; NERVE INJURY; NICK END LABELING; NONHUMAN; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PENIS ERECTION; PRIORITY JOURNAL; RAT; SHORT COURSE THERAPY; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 44949086623     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00776.x     Document Type: Article

References (26)

1. Meng MV, Elkin EP, Harlan SR, Mehta SS, Lubeck DP, Carroll PR. Predictors of treatment after initial surveillance in men with prostate cancer: Results from caPSURE. J Urol 2003; 170: 2279-83.
2. Walsh PC, Donker PJ. Impotence following radical prostatectomy: Insight into etiology and prevention. J Urol 1982; 128: 492-7.
3. Catalona WJ, Carvalhal GF, Mager DE, Smith DS. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999; 162: 433-8.
4. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000; 164: 1929-34.
5. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000; 55: 58-61.
6. Burnett AL. Neuroprotection and nerve grafts in the treatment of neurogenic erectile dysfunction. J Urol 2003; 170: S31-4.
7. Burgers JK, Nelson RJ, Quinlan DM, Walsh PC. Nerve growth factor, nerve grafts and amniotic membrane grafts restore erectile function in rats. J Urol 1991; 146: 463-8.
8. Ball RA, Lipton SA, Dreyer EB, Richie JP, Vickers MA. Entubulization repair of severed cavernous nerves in the rat resulting in return of erectile function. J Urol 1992; 148: 211-5.
9. Te AE, Santarosa RP, Koo HP, Buttyan R, Greene LA, Kaplan SA, Olsson CA, Shabsigh R. Neurotrophic factors in the rat penis. J Urol 1994; 152: 2167-72.
10. Dahiya R, Chui R, Perinchery G, Nakajima K, Oh BR, Lue TF. Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction. Int J Impot Res 1999; 11: 201-6.
11. Sezen SF, Hoke A, Burnett AL, Snyder SH. Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat Med 2001; 7: 1073-4.
12. Sezen SF, Blackshaw S, Steiner JP, Burnett AL. FK506 binding protein 12 is expressed in rat penile innervation and upregulated after cavernous nerve injury. Int J Impot Res 2002; 14: 506-12.
13. Snyder SH, Sabatini DM, Lai MM, Steiner JP, Hamilton GS, Suzdak PD. Neural actions of immunophilin ligands. Trends Pharmacol Sci 1998; 19: 21-6.
14. Burnett AL, Becker RE. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J Urol 2004; 171: 495-500.
15. Mullerad M, Donohue JF, Li PS, Scardino PT, Mulhall JP. Functional sequelae of cavernous nerve injury in the rat: Is there model dependency. J Sex Med 2006; 3: 77-83.
16. Lyons WE, Steiner JP, Snyder SH, Dawson TM. Neuronal regeneration enhances the expression of the immunophilin FKBP-12. J Neurosci 1995; 15: 2985-94.
17. Gold BG, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J Neurosci 1995; 15: 7509-16.
18. Wang MS, Gold BG. FK506 increases the regeneration of spinal cord axons in a predegenerated peripheral nerve autograft. J Spinal Cord Med 1999; 22: 287-96.
19. Verkade P, Schrama LH, Verkleij AJ, Gispen WH, Oestreicher AB. Ultrastructural co-localization of calmodulin and B-50/growth-associated protein-43 at the plasma membrane of proximal unmyelinated axon shafts studied in the model of the regenerating rat sciatic nerve. Neuroscience 1997; 79: 1207-18.
20. Verkade P, Oestreicher AB, Verkleij AJ, Gispen WH. The increase in B-50/ GAP-43 in regenerating rat sciatic nerve occurs predominantly in unmyelinated axon shafts: A quantitative ultrastructural study. J Comp Neurol 1995; 356: 433-43.
21. Donohue JF, Tal R, Akin-Olugbade Y, Mullerad M, Muller A, Bennett N, Kobylarz K, Paduch DA, Scardino PT, Mulhall JP. Sildenafil and Cavernous Nerve Injury in the Rat: Defining the Optimal Dosing and Timing Regimen. AUA Atlanta 2006, Abstract #993, p. 1205.
22. Carrier S, Zvara P, Nunes L, Kour NW, Rehman J, Lue TF. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol 1995; 153: 1722-7.
23. Liu Y, Meiri KF, Cynader MS, Gu Q. Nerve growth factor induced modification of presynaptic elements in adult visual cortex in vivo. Brain Res 1996; 732: 36-42.
24. Grosskreutz CL, Hanninen VA, Pantcheva MB, Huang W, Poulin NR, Dobbberfuhl AP. FK506 blocks activation of the intrinsic caspase cascade after optic nerve crush. Exp Eye Res 2005; 80: 681-6.
25. Furuichi Y, Noto T, Li JY, Oku T, Ishiye M, Moriguchi A, Armaori I, Matsuoka N, Mutoh S, Yanagihara T. Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats. Brain Res 2004; 1014: 120-30.
26. Bella AJ, Hayashi N, Carrione RE, Price R, Lue TF. FK1706 enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat. J Sex Med 2007; 4: 341-6; discussion 346-7.